BioMarin Pharmaceutical, Inc. (BMRN)
65.04
-1.66
(-2.50%)
USD |
NASDAQ |
Aug 24, 16:00
65.04
0.00 (0.00%)
After-Hours: 20:00
BioMarin Pharmaceutical Total Assets (Quarterly) : 11.72B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.72B |
| March 31, 2026 | 8.591B |
| December 31, 2025 | 7.594B |
| September 30, 2025 | 7.615B |
| June 30, 2025 | 7.456B |
| March 31, 2025 | 7.147B |
| December 31, 2024 | 6.989B |
| September 30, 2024 | 6.851B |
| June 30, 2024 | 7.067B |
| March 31, 2024 | 6.873B |
| December 31, 2023 | 6.842B |
| September 30, 2023 | 6.758B |
| June 30, 2023 | 6.563B |
| March 31, 2023 | 6.434B |
| December 31, 2022 | 6.375B |
| September 30, 2022 | 6.264B |
| June 30, 2022 | 6.146B |
| March 31, 2022 | 6.063B |
| December 31, 2021 | 6.003B |
| September 30, 2021 | 5.977B |
| June 30, 2021 | 5.898B |
| March 31, 2021 | 5.805B |
| December 31, 2020 | 5.848B |
| September 30, 2020 | 6.158B |
| June 30, 2020 | 5.302B |
| Date | Value |
|---|---|
| March 31, 2020 | 4.723B |
| December 31, 2019 | 4.690B |
| September 30, 2019 | 4.558B |
| June 30, 2019 | 4.393B |
| March 31, 2019 | 4.435B |
| December 31, 2018 | 4.489B |
| September 30, 2018 | 4.695B |
| June 30, 2018 | 4.625B |
| March 31, 2018 | 4.597B |
| December 31, 2017 | 4.677B |
| September 30, 2017 | 4.581B |
| June 30, 2017 | 4.020B |
| March 31, 2017 | 3.939B |
| December 31, 2016 | 4.024B |
| September 30, 2016 | 3.842B |
| June 30, 2016 | 3.087B |
| March 31, 2016 | 3.667B |
| December 31, 2015 | 3.729B |
| September 30, 2015 | 3.625B |
| June 30, 2015 | 3.649B |
| March 31, 2015 | 3.659B |
| December 31, 2014 | 2.490B |
| September 30, 2014 | 2.440B |
| June 30, 2014 | 2.346B |
| March 31, 2014 | 2.341B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Incyte Corp. | 7.873B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Vertex Pharmaceuticals, Inc. | 27.42B |
| Ionis Pharmaceuticals, Inc. | 2.995B |
| Regeneron Pharmaceuticals, Inc. | 41.73B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.402B |
| Shareholders Equity (Quarterly) | 6.322B |
| Debt to Equity Ratio | 0.6672 |
| Current Ratio | 2.387 |
| Net Debt Paydown Yield | -6.52% |